Davis Selected Advisers’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $317M | Buy |
1,617,813
+27,930
| +2% | +$5.43M | 1.46% | 25 |
|
|
2025
Q4 | $276M | Buy |
1,589,883
+228,271
| +17% | +$41.6M | 1.24% | 23 |
|
|
2025
Q3 | $259M | Buy |
1,361,612
+7,192
| +0.5% | +$1.28M | 1.35% | 22 |
|
|
2025
Q2 | $243M | Sell |
1,354,420
-1,033,882
| -43% | -$180M | 1.3% | 22 |
|
|
2025
Q1 | $404M | Sell |
2,388,302
-8,958
| -0.4% | -$1.47M | 2.33% | 17 |
|
|
2024
Q4 | $362M | Sell |
2,397,260
-1,843
| -0.1% | -$287K | 2.1% | 17 |
|
|
2024
Q3 | $372M | Buy |
2,399,103
+8,275
| +0.3% | +$1.24M | 2.09% | 18 |
|
|
2024
Q2 | $327M | Buy |
2,390,828
+9,665
| +0.4% | +$1.32M | 1.9% | 21 |
|
|
2024
Q1 | $317M | Sell |
2,381,163
-285,401
| -11% | -$37M | 1.78% | 21 |
|
|
2023
Q4 | $368M | Buy |
2,666,564
+998,866
| +60% | +$131M | 2.08% | 20 |
|
|
2023
Q3 | $203M | Buy |
1,667,698
+153,810
| +10% | +$20.5M | 1.27% | 21 |
|
|
2023
Q2 | $213M | Sell |
1,513,888
-4,864
| -0.3% | -$671K | 1.3% | 20 |
|
|
2023
Q1 | $215M | Sell |
1,518,752
-317,071
| -17% | -$45.4M | 1.42% | 21 |
|
|
2022
Q4 | $287M | Sell |
1,835,823
-35,337
| -2% | -$5.08M | 1.95% | 21 |
|
|
2022
Q3 | $230M | Sell |
1,871,160
-18,655
| -1% | -$2.46M | 1.63% | 21 |
|
|
2022
Q2 | $251M | Sell |
1,889,815
-57,243
| -3% | -$7.8M | 1.61% | 22 |
|
|
2022
Q1 | $266M | Sell |
1,947,058
-59,570
| -3% | -$8.3M | 1.35% | 23 |
|
|
2021
Q4 | $347M | Sell |
2,006,628
-736,328
| -27% | -$112M | 1.61% | 21 |
|
|
2021
Q3 | $399M | Sell |
2,742,956
-72,658
| -3% | -$10.6M | 1.84% | 19 |
|
|
2021
Q2 | $372M | Buy |
2,815,614
+37,508
| +1% | +$4.91M | 1.53% | 20 |
|
|
2021
Q1 | $357M | Sell |
2,778,106
-149,852
| -5% | -$18.5M | 1.56% | 21 |
|
|
2020
Q4 | $349M | Sell |
2,927,958
-818,355
| -22% | -$99.8M | 1.68% | 21 |
|
|
2020
Q3 | $429M | Sell |
3,746,313
-128,261
| -3% | -$15.2M | 2.39% | 19 |
|
|
2020
Q2 | $442M | Buy |
3,874,574
+7,716
| +0.2% | +$818K | 2.55% | 19 |
|
|
2020
Q1 | $311M | Sell |
3,866,858
-37,629
| -1% | -$3.9M | 2.1% | 18 |
|
|
2019
Q4 | $417M | Sell |
3,904,487
-73,965
| -2% | -$7.71M | 1.99% | 19 |
|
|
2019
Q3 | $426M | Sell |
3,978,452
-22,718
| -0.6% | -$2.33M | 2.14% | 18 |
|
|
2019
Q2 | $407M | Buy |
4,001,170
+362,109
| +10% | +$34.8M | 2.01% | 18 |
|
|
2019
Q1 | $327M | Buy |
3,639,061
+2,840,669
| +356% | +$246M | 1.61% | 20 |
|
|
2018
Q4 | $66.3M | Buy |
798,392
+665,853
| +502% | +$62.4M | 0.37% | 34 |
|
|
2018
Q3 | $14.3M | Sell |
132,539
-618
| -0.5% | -$67.8K | 0.06% | 83 |
|
|
2018
Q2 | $14.6M | Sell |
133,157
-218
| -0.2% | -$22.7K | 0.06% | 84 |
|
|
2018
Q1 | $13.4M | Buy |
133,375
+678
| +0.5% | +$69.4K | 0.06% | 85 |
|
|
2017
Q4 | $13.1M | Buy |
132,697
+42
| +0% | +$3.98K | 0.06% | 86 |
|
|
2017
Q3 | $12.4M | Buy |
132,655
+66
| +0% | +$7.01K | 0.05% | 98 |
|
|
2017
Q2 | $14.7M | Buy |
132,589
+3,170
| +2% | +$335K | 0.06% | 89 |
|
|
2017
Q1 | $12.7M | Sell |
129,419
-74,279
| -36% | -$7.08M | 0.05% | 96 |
|
|
2016
Q4 | $18.7M | Sell |
203,698
-36,198
| -15% | -$3.12M | 0.08% | 76 |
|
|
2016
Q3 | $20.3M | Sell |
239,896
-3,039,598
| -93% | -$255M | 0.09% | 68 |
|
|
2016
Q2 | $267M | Sell |
3,279,494
-35,278
| -1% | -$2.69M | 1.18% | 30 |
|
|
2016
Q1 | $237M | Sell |
3,314,772
-276,085
| -8% | -$18.5M | 1.05% | 33 |
|
|
2015
Q4 | $255M | Sell |
3,590,857
-612,934
| -15% | -$41.2M | 1.07% | 35 |
|
|
2015
Q3 | $258M | Sell |
4,203,791
-776,691
| -16% | -$54.3M | 1.07% | 33 |
|
|
2015
Q2 | $361M | Sell |
4,980,482
-88,443
| -2% | -$6.53M | 1.26% | 26 |
|
|
2015
Q1 | $390M | Sell |
5,068,925
-86,758
| -2% | -$6.21M | 1.33% | 22 |
|
|
2014
Q4 | $346M | Buy |
5,155,683
+276,267
| +6% | +$17.4M | 1.12% | 29 |
|
|
2014
Q3 | $296M | Buy |
4,879,416
+206,735
| +4% | +$12.7M | 0.92% | 33 |
|
|
2014
Q2 | $274M | Buy |
4,672,681
+4,570,344
| +4,466% | +$268M | 0.82% | 34 |
|
|
2014
Q1 | $5.93M | Buy |
+102,337
| New | +$5.48M | 0.02% | 147 |
|
Other funds holding DGX
VCM
VPM
EIG
Davis Selected Advisers's DGX Position: Q1 2026 in Review
Davis Selected Advisers increased its Quest Diagnostics (DGX) stake by 1.8% in Q1 2026, buying an estimated $5.43M and bringing the position to 1,617,813 shares worth $317M. The position accounts for 1.46% of the portfolio, ranked #25.
Davis Selected Advisers first reported a position in DGX in Q1 2014 and has held it in 49 quarters since. The position peaked at $442M in Q2 2020. 1,066 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Davis Selected Advisers held 1,617,813 shares of Quest Diagnostics worth $317M as of Q1 2026.
- Davis Selected Advisers bought 27,930 Quest Diagnostics shares in Q1 2026, an estimated $5.43M.
- Quest Diagnostics made up 1.46% of Davis Selected Advisers's portfolio in Q1 2026, its #25 holding.
- Davis Selected Advisers first reported a position in Quest Diagnostics in Q1 2014 and has held it in 49 quarters since.
- Davis Selected Advisers's Quest Diagnostics position peaked at $442M in Q2 2020.
- 1,066 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Davis Selected Advisers's 13F filing for Q1 2026, filed 7 May 2026.